SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
03-May-24 8:45 AM View: | Revance Therapeutics, Inc. (RVNC) | 01-May-24 | Grant | 15,000 | -- | -- | 91% 16.56K to 31.56K | |
20-Jun-23 4:25 PM View: | Revance Therapeutics, Inc. (RVNC) | 15-Jun-23 | Option Exercise | 2,500 | $18.12 | $45,300.00 | 15% 16.56K to 19.06K | |
20-Jun-23 4:25 PM View: | Revance Therapeutics, Inc. (RVNC) | 15-Jun-23 | Planned Option Sale | 2,500 | $28.24 | $70,600.00 | (13%) 19.06K to 16.56K | |
05-May-23 5:14 PM View: | Revance Therapeutics, Inc. (RVNC) | 03-May-23 | Grant | 3,534 | -- | -- | 27% 13.03K to 16.56K | |
06-May-22 6:19 PM View: | Revance Therapeutics, Inc. (RVNC) | 04-May-22 | Grant | 6,059 | -- | -- | 87% 6.97K to 13.03K | |
07-May-21 7:08 PM View: | Revance Therapeutics, Inc. (RVNC) | 05-May-21 | Grant | 674 | -- | -- | 11% 6.29K to 6.97K | |
02-Mar-21 8:17 PM View: | Revance Therapeutics, Inc. (RVNC) | 01-Mar-21 | Grant | 6,294 | -- | -- | 100% 0 to 6.29K |